OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial
Christian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
Journal of Infection (2023) Vol. 87, Iss. 3, pp. 242-254
Closed Access | Times Cited: 12
Christian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
Journal of Infection (2023) Vol. 87, Iss. 3, pp. 242-254
Closed Access | Times Cited: 12
Showing 12 citing articles:
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 10
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 10
Vaccine development against tuberculosis before and after Covid-19
Stefan H. E. Kaufmann
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Stefan H. E. Kaufmann
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Kopfschmerz zurückzuführen auf eine Substanz oder deren Entzug
Hartmut Göbel
Springer eBooks (2025), pp. 845-894
Closed Access
Hartmut Göbel
Springer eBooks (2025), pp. 845-894
Closed Access
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up
Zafer Sezer, Shaikh Terkıs Islam Pavel, Ahmet İnal, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 140-140
Open Access | Times Cited: 2
Zafer Sezer, Shaikh Terkıs Islam Pavel, Ahmet İnal, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 140-140
Open Access | Times Cited: 2
COVID-19 vaccine updates for people under different conditions
Yi-Jiao Huang, Weiyang Wang, Yan Liu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2323-2343
Closed Access | Times Cited: 2
Yi-Jiao Huang, Weiyang Wang, Yan Liu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 11, pp. 2323-2343
Closed Access | Times Cited: 2
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
Altijana Hromić‐Jahjefendić, Kenneth Lundström, Muhamed Adilović, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 3, pp. 103508-103508
Closed Access | Times Cited: 4
Altijana Hromić‐Jahjefendić, Kenneth Lundström, Muhamed Adilović, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 3, pp. 103508-103508
Closed Access | Times Cited: 4
Omicron breakthrough infections after triple‐dose inactivated COVID ‐19 vaccination: A comprehensive analysis of antibody and T‐cell responses
Tiandan Xiang, Xufeng Quan, Hang Jia, et al.
Immunology (2024) Vol. 172, Iss. 2, pp. 313-327
Open Access | Times Cited: 1
Tiandan Xiang, Xufeng Quan, Hang Jia, et al.
Immunology (2024) Vol. 172, Iss. 2, pp. 313-327
Open Access | Times Cited: 1
COVID-19 Reinfection: Can Humoral or Cellular Immune Status Predict need for Vaccination and which Vaccine is more Effective: mRNA Booster or Inactivated whole Virus (VLA2001)?
K Erpenbach, Erpenbach AS, W Mayer, et al.
Journal of Immunology Research & Reports (2024) Vol. 4, Iss. 1, pp. 1-5
Open Access
K Erpenbach, Erpenbach AS, W Mayer, et al.
Journal of Immunology Research & Reports (2024) Vol. 4, Iss. 1, pp. 1-5
Open Access
RNAi-mediated inhibition of SARS-CoV-2: applications and challenges
Debosmita Sanyal, Binay Chaubey
Future Virology (2024) Vol. 19, Iss. 2-4, pp. 127-143
Closed Access
Debosmita Sanyal, Binay Chaubey
Future Virology (2024) Vol. 19, Iss. 2-4, pp. 127-143
Closed Access
Effect of Homologous and Heterologous Booster in COVID-19 Vaccination
Marija Vukčević, Mateja Despot, Aleksandra Nikolić‐Kokić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1734-1734
Open Access
Marija Vukčević, Mateja Despot, Aleksandra Nikolić‐Kokić, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1734-1734
Open Access
The Covid-19 and TB Syndemic: Differences and Similarities
Stefan H. E. Kaufmann, Alan Sher, Alex Sigal, et al.
Frontiers research topics (2023)
Open Access
Stefan H. E. Kaufmann, Alan Sher, Alex Sigal, et al.
Frontiers research topics (2023)
Open Access
